Cancer and vaccines – the two most divisive issues in medicine?

This week we report on what are probably the two most divisive issues in medicine and healthcare. Cancer research and treatments, and childhood vaccination schedules. Both represent very big businesses, with global spending on cancer treatments nudging $200 billion, and that for vaccination $60 billion. Don’t think of vaccines as a minor player compared with oncologics — given how quickly jabs or nasal sprays can be delivered and what the take-up is, in return-on-investment (ROI) terms, they are akin to kryptonite!

Our first story this week picks up on last weekend’s conference organised by our strategic partners at integrative medicine charity, Yes to Life. The essence of the meeting was bringing to light the latest research that suggests the cancer research community has spent far too long chasing oncogenes as therapeutic targets. Instead it should be looking at cancer as a metabolic disease, which in turn requires a very different approach to management. We heard from experts, we heard from patients, some stage IV doing very well on ketogenic diets, others fully recovered from so-called terminal disease, often as a result of personalised and integrated approaches

Fuelled by our recent trips to Australia and California where parents are under huge pressure to subject their children to the full vaccination schedule, along with the work of our colleagues at ANH-USA on aluminium in vaccines, we’ve pulled together what we hope is some useful information on 5 key issues that concern many parents.

If you need a break from news about the political mayhem that abounds either side of the Atlantic – you can keep yourself up-to-date, as always, with our weekly natural news roundup.

In health, naturally

 

Rob Verkerk, PhD

Founder, executive & scientific director